Cross-talk between IGF-1 and estrogen receptors attenuates intracellular changes in ventral spinal cord 4.1 motoneuron cells because of interferon-gamma exposure

Journal of Neurochemistry

Volumn 128, Issue 6, 2014, Pages 904-918

  Park, Sookyoung ^a   Nozaki, Kenkichi ^a   Smith, Joshua A ^a   Krause, James S ^a   Banik, Naren L ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

apoptosis; calpain; estrogen receptor; IGF 1; IGF 1 receptor

Indexed keywords

CALPAIN; CALPASTATIN; CASPASE 12; CASPASE 2; CYCLOOXYGENASE 2; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GAMMA INTERFERON; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BAX; PROTEIN BCL 2; SMALL INTERFERING RNA; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ANIMAL CELL; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; ENZYME ACTIVITY; INTRACELLULAR SIGNALING; MOLECULAR INTERACTION; MOTONEURON; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; VENTRAL ROOT;

APOPTOSIS; CALPAIN; ESTROGEN RECEPTOR; IGF-1; IGF-1 RECEPTOR;

ANIMALS; APOPTOSIS; CALPAIN; CELL LINE; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; INSULIN-LIKE GROWTH FACTOR I; INTERFERON-GAMMA; MICE; MOTOR NEURONS; NEUROBLASTOMA; NEUROPROTECTIVE AGENTS; RATS; RECEPTOR CROSS-TALK; RNA, SMALL INTERFERING; SPINAL CORD;

EID: 84895917810     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12520     Document Type: Article

References (75)

1. Arroba A. I., Wallace D., Mackey A., de la Rosa E. J., and, Cotter T. G., (2009) IGF-I maintains calpastatin expression and attenuates apoptosis in several models of photoreceptor cell death. Eur. J. Neurosci. 30, 975-986.
2. Azcoitia I., Sierra A., and, Garcia-Segura L. M., (1999) Neuroprotective effects of estradiol in the adult rat hippocampus: interaction with insulin-like growth factor-I signalling. J. Neurosci. Res. 58, 815-822.
3. Bal-Price A., Moneer Z., and, Brown G. C., (2002) Nitric oxide induces rapid, calcium-dependent release of vesicular glutamate and ATP from cultured rat astrocytes. Glia 40, 312-323.
4. Banik N. L., Hogan E. L., Jenkins M. G., McDonald J. K., McAlhaney W. W., and, Sostek M. B., (1983) Purification of a calcium-activated neutral proteinase from bovine brain. Neurochem. Res. 8, 1389-1405.
5. Banik N. L., Chakrabarti A. K., Konat G. W., Gantt-Wilford G., and, Hogan E. L., (1992) Calcium-activated neutral proteinase (calpain) activity in C6 cell line: compartmentation of mu and m calpain. J. Neurosci. Res. 31, 708-714.
6. Beck K. D., Powell-Braxton L., Widmer H. R., Valverde J., and, Hefti F., (1995) Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons. Neuron 14, 717-730.
7. Blomgren K., Hallin U., Andersson A. L., Puka-Sundvall M., Bahr B. A., McRae A., Saido T. C., Kawashima S., and, Hagberg H., (1999) Calpastatin is up-regulated in response to hypoxia and is a suicide substrate to calpain after neonatal cerebral hypoxia-ischemia. J. Biol. Chem. 274, 14046-14052.
8. Butler A. A., Yakar S., Gewolb I. H., Karas M., Okubo Y., and, LeRoith D., (1998) Insulin-like growth factor-I receptor signal transduction: at the interface between physiology and cell biology. Comp. Biochem. Physiol. B, Biochem. Mol. Biol. 121, 19-26.
9. Campbell R. A., Bhat-Nakshatri P., Patel N. M., Constantinidou D., Ali S., and, Nakshatri H., (2001) Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance. J. Biol. Chem. 276, 9817-9824.
10. Cardona-Gomez G. P., Mendez P., DonCarlos L. L., Azcoitia I., and, Garcia-Segura L. M., (2002) Interactions of estrogen and insulin-like growth factor-I in the brain: molecular mechanisms and functional implications. J. Steroid Biochem. Mol. Biol. 83, 211-217.
11. Carrer H. F., Araque A., and, Buno W., (2003) Estradiol regulates the slow Ca2 + -activated K+ current in hippocampal pyramidal neurons. J. Neurosci. 23, 6338-6344.
12. Chesik D., De Keyser J., and, Wilczak N., (2007) Insulin-like growth factor binding protein-2 as a regulator of IGF actions in CNS: implications in multiple sclerosis. Cytokine Growth Factor Rev. 18, 267-278.
13. Crawford G. D., Jr, Le W. D., Smith R. G., Xie W. J., Stefani E., and, Appel S. H., (1992) A novel N18TG2 x mesencephalon cell hybrid expresses properties that suggest a dopaminergic cell line of substantia nigra origin. J. Neurosci. 12, 3392-3398.
14. Croci L., Barili V., Chia D., Massimino L., van Vugt R., Masserdotti G., Longhi R., Rotwein P., and, Consalez G. G., (2011) Local insulin-like growth factor I expression is essential for Purkinje neuron survival at birth. Cell Death Differ. 18, 48-59.
15. Diaz-Sanchez M., Williams K., DeLuca G. C., and, Esiri M. M., (2006) Protein co-expression with axonal injury in multiple sclerosis plaques. Acta Neuropathol. 111, 289-299.
16. Ding Q., Vaynman S., Akhavan M., Ying Z., and, Gomez-Pinilla F., (2006) Insulin-like growth factor I interfaces with brain-derived neurotrophic factor-mediated synaptic plasticity to modulate aspects of exercise-induced cognitive function. Neuroscience 140, 823-833.
17. Dobrowolny G., Giacinti C., Pelosi L., Nicoletti C., Winn N., Barberi L., Molinaro M., Rosenthal N., and, Musaro A., (2005) Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model. J. Cell Biol. 168, 193-199.
18. Dudek H., Datta S. R., Franke T. F., Birnbaum M. J., Yao R., Cooper G. M., Segal R. A., Kaplan D. R., and, Greenberg M. E., (1997) Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 275, 661-665.
19. Duenas M., Torres-Aleman I., Naftolin F., and, Garcia-Segura L. M., (1996) Interaction of insulin-like growth factor-I and estradiol signaling pathways on hypothalamic neuronal differentiation. Neuroscience 74, 531-539.
20. Gao G., and, Dou Q. P., (2000) N-terminal cleavage of bax by calpain generates a potent proapoptotic 18-kDa fragment that promotes bcl-2-independent cytochrome C release and apoptotic cell death. J. Cell. Biochem. 80, 53-72.
21. Gao H. M., Kotzbauer P. T., Uryu K., Leight S., Trojanowski J. Q., and, Lee V. M., (2008) Neuroinflammation and oxidation/nitration of alpha-synuclein linked to dopaminergic neurodegeneration. J. Neurosci. 28, 7687-7698.
22. Garcia-Segura L. M., Cardona-Gomez G. P., Chowen J. A., and, Azcoitia I., (2000) Insulin-like growth factor-I receptors and estrogen receptors interact in the promotion of neuronal survival and neuroprotection. J. Neurocytol. 29, 425-437.
23. Garcia-Segura L. M., Sanz A., and, Mendez P., (2006) Cross-talk between IGF-I and estradiol in the brain: focus on neuroprotection. Neuroendocrinology 84, 275-279.
24. Garcia-Segura L. M., Arevalo M. A., and, Azcoitia I., (2010) Interactions of estradiol and insulin-like growth factor-I signalling in the nervous system: new advances. Prog. Brain Res. 181, 251-272.
25. Gardoni F., Boraso M., Zianni E., Corsini E., Galli C. L., Cattabeni F., Marinovich M., Di Luca M., and, Viviani B., (2011) Distribution of interleukin-1 receptor complex at the synaptic membrane driven by interleukin-1beta and NMDA stimulation. J. Neuroinflammation 8, 14.
26. Gonzalez C., Diaz F., and, Alonso A., (2008) Neuroprotective effects of estrogens: cross-talk between estrogen and intracellular insulin signalling. Infect. Disord. Drug Targets 8, 65-67.
27. Guerrero A. R., Uchida K., Nakajima H., Watanabe S., Nakamura M., Johnson W. E., and, Baba H., (2012) Blockade of interleukin-6 signaling inhibits the classic pathway and promotes an alternative pathway of macrophage activation after spinal cord injury in mice. J. Neuroinflammation 9, 40.
28. Higuchi M., Tomioka M., Takano J., Shirotani K., Iwata N., Masumoto H., Maki M., Itohara S., and, Saido T. C., (2005) Distinct mechanistic roles of calpain and caspase activation in neurodegeneration as revealed in mice overexpressing their specific inhibitors. J. Biol. Chem. 280, 15229-15237.
29. Huang Y., Liu J., Wang L. Z., Zhang W. Y., and, Zhu X. Z., (2005) Neuroprotective effects of cyclooxygenase-2 inhibitor celecoxib against toxicity of LPS-stimulated macrophages toward motor neurons. Acta Pharmacol. Sin. 26, 952-958.
30. Kahlert S., Nuedling S., van Eickels M., Vetter H., Meyer R., and, Grohe C., (2000) Estrogen receptor alpha rapidly activates the IGF-1 receptor pathway. J. Biol. Chem. 275, 18447-18453.
31. Lassmann H., and, Ransohoff R. M., (2004) The CD4-Th1 model for multiple sclerosis: a critical [correction of crucial] re-appraisal. Trends Immunol. 25, 132-137.
32. Li P., Nijhawan D., Budihardjo I., Srinivasula S. M., Ahmad M., Alnemri E. S., and, Wang X., (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91, 479-489.
33. Linseman D. A., McClure M. L., Bouchard R. J., Laessig T. A., Ahmadi F. A., and, Heidenreich K. A., (2002a) Suppression of death receptor signaling in cerebellar Purkinje neurons protects neighboring granule neurons from apoptosis via an insulin-like growth factor I-dependent mechanism. J. Biol. Chem. 277, 24546-24553.
34. Linseman D. A., Phelps R. A., Bouchard R. J., Le S. S., Laessig T. A., McClure M. L., and, Heidenreich K. A., (2002b) Insulin-like growth factor-I blocks Bcl-2 interacting mediator of cell death (Bim) induction and intrinsic death signaling in cerebellar granule neurons. J. Neurosci. 22, 9287-9297.
35. Lopatniuk P., and, Witkowski J. M., (2011) Conventional calpains and programmed cell death. Acta Biochim. Pol. 58, 287-296.
36. Lopez-Lopez C., LeRoith D., and, Torres-Aleman I., (2004) Insulin-like growth factor I is required for vessel remodeling in the adult brain. Proc. Natl Acad. Sci. USA 101, 9833-9838.
37. Mason J. L., Ye P., Suzuki K., D'Ercole A. J., and, Matsushima G. K., (2000) Insulin-like growth factor-1 inhibits mature oligodendrocyte apoptosis during primary demyelination. J. Neurosci. 20, 5703-5708.
38. Meda L., Cassatella M. A., Szendrei G. I., Otvos L., Jr, Baron P., Villalba M., Ferrari D., and, Rossi F., (1995) Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature 374, 647-650.
39. Mendez P., Wandosell F., and, Garcia-Segura L. M., (2006) Cross-talk between estrogen receptors and insulin-like growth factor-I receptor in the brain: cellular and molecular mechanisms. Front. Neuroendocrinol. 27, 391-403.
40. Mermelstein P. G., Becker J. B., and, Surmeier D. J., (1996) Estradiol reduces calcium currents in rat neostriatal neurons via a membrane receptor. J. Neurosci. 16, 595-604.
41. Mustafa A., Lannfelt L., Lilius L., Islam A., Winblad B., and, Adem A., (1999) Decreased plasma insulin-like growth factor-I level in familial Alzheimer's disease patients carrying the Swedish APP 670/671 mutation. Dement. Geriatr. Cogn. Disord. 10, 446-451.
42. Nakagawa T., Zhu H., Morishima N., Li E., Xu J., Yankner B. A., and, Yuan J., (2000) Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 403, 98-103.
43. Nakajima K., and, Kohsaka S., (2001) Microglia: activation and their significance in the central nervous system. J. Biochem. 130, 169-175.
44. Narai H., Nagano I., Ilieva H., Shiote M., Nagata T., Hayashi T., Shoji M., and, Abe K., (2005) Prevention of spinal motor neuron death by insulin-like growth factor-1 associating with the signal transduction systems in SODG93A transgenic mice. J. Neurosci. Res. 82, 452-457.
45. Nicotra A., and, Parvez S., (2002) Apoptotic molecules and MPTP-induced cell death. Neurotoxicol. Teratol. 24, 599-605.
46. Nozaki K., Das A., Ray S. K., and, Banik N. L., (2011) Calpeptin attenuated apoptosis and intracellular inflammatory changes in muscle cells. J. Neurosci. Res. 89, 536-543.
47. Ono S., Hu J., Shimizu N., Imai T., and, Nakagawa H., (2001) Increased interleukin-6 of skin and serum in amyotrophic lateral sclerosis. J. Neurol. Sci. 187, 27-34.
48. Park S., Nozaki K., Guyton M. K., Smith J. A., Ray S. K., and, Banik N. L., (2012) Calpain inhibition attenuated morphological and molecular changes in skeletal muscle of experimental allergic encephalomyelitis rats. J. Neurosci. Res. 90, 2134-2145.
49. Pons S., and, Torres-Aleman I., (2000) Insulin-like growth factor-I stimulates dephosphorylation of ikappa B through the serine phosphatase calcineurin (protein phosphatase 2B). J. Biol. Chem. 275, 38620-38625.
50. Quesada A., and, Micevych P. E., (2004) Estrogen interacts with the IGF-1 system to protect nigrostriatal dopamine and maintain motoric behavior after 6-hydroxdopamine lesions. J. Neurosci. Res. 75, 107-116.
51. Quesada A., Romeo H. E., and, Micevych P., (2007) Distribution and localization patterns of estrogen receptor-beta and insulin-like growth factor-1 receptors in neurons and glial cells of the female rat substantia nigra: localization of ERbeta and IGF-1R in substantia nigra. J. Comp. Neurol. 503, 198-208.
52. Rogers J., and, Lue L. F., (2001) Microglial chemotaxis, activation, and phagocytosis of amyloid beta-peptide as linked phenomena in Alzheimer's disease. Neurochem. Int. 39, 333-340.
53. Samantaray S., Knaryan V. H., Le Gal C., Ray S. K., and, Banik N. L., (2011a) Calpain inhibition protected spinal cord motoneurons against 1-methyl-4-phenylpyridinium ion and rotenone. Neuroscience 192, 263-274.
54. Samantaray S., Smith J. A., Das A., Matzelle D. D., Varma A. K., Ray S. K., and, Banik N. L., (2011b) Low dose estrogen prevents neuronal degeneration and microglial reactivity in an acute model of spinal cord injury: effect of dosing, route of administration, and therapy delay. Neurochem. Res. 36, 1809-1816.
55. Sanchez J. C., Lopez-Zapata D. F., Francis L., and, De Los Reyes L., (2011) Effects of estradiol and IGF-1 on the sodium calcium exchanger in rat cultured cortical neurons. Cell. Mol. Neurobiol. 31, 619-627.
56. Sawada M., Imamura K., and, Nagatsu T,. (2006) Role of cytokines in inflammatory process in Parkinson's disease. J. Neural Transm. Suppl. 70, 373-381.
57. Sekizawa T., Openshaw H., Ohbo K., Sugamura K., Itoyama Y., and, Niland J. C., (1998) Cerebrospinal fluid interleukin 6 in amyotrophic lateral sclerosis: immunological parameter and comparison with inflammatory and non-inflammatory central nervous system diseases. J. Neurol. Sci. 154, 194-199.
58. Selvamani A., and, Sohrabji F., (2010) The neurotoxic effects of estrogen on ischemic stroke in older female rats is associated with age-dependent loss of insulin-like growth factor-1. J. Neurosci. 30, 6852-6861.
59. Shields D. C., Schaecher K. E., Saido T. C., and, Banik N. L., (1999) A putative mechanism of demyelination in multiple sclerosis by a proteolytic enzyme, calpain. Proc. Natl Acad. Sci. USA 96, 11486-11491.
60. Skihar V., Silva C., Chojnacki A., Doring A., Stallcup W. B., Weiss S., and, Yong V. W., (2009) Promoting oligodendrogenesis and myelin repair using the multiple sclerosis medication glatiramer acetate. Proc. Natl Acad. Sci. USA 106, 17992-17997.
61. Smith R. G., Alexianu M. E., Crawford G., Nyormoi O., Stefani E., and, Appel S. H., (1994) Cytotoxicity of immunoglobulins from amyotrophic lateral sclerosis patients on a hybrid motoneuron cell line. Proc. Natl Acad. Sci. USA 91, 3393-3397.
62. Smith J. A., Das A., Ray S. K., and, Banik N. L., (2012) Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Res. Bull. 87, 10-20.
63. Sribnick E. A., Ray S. K., and, Banik N. L., (2006) Estrogen prevents glutamate-induced apoptosis in C6 glioma cells by a receptor-mediated mechanism. Neuroscience 137, 197-209.
64. Su X., Maguire-Zeiss K. A., Giuliano R., Prifti L., Venkatesh K., and, Federoff H. J., (2008) Synuclein activates microglia in a model of Parkinson's disease. Neurobiol. Aging 29, 1690-1701.
65. Swardfager W., Lanctot K., Rothenburg L., Wong A., Cappell J., and, Herrmann N., (2010) A meta-analysis of cytokines in Alzheimer's disease. Biol. Psychiatry 68, 930-941.
66. Thompson C. D., Zurko J. C., Hanna B. F., Hellenbrand D. J., and, Hanna A., (2013) The therapeutic role of interleukin-10 after spinal cord injury. J. Neurotrauma 30, 1311-1324.
67. Torres-Aleman I., Barrios V., Lledo A., and, Berciano J., (1996) The insulin-like growth factor I system in cerebellar degeneration. Ann. Neurol. 39, 335-342.
68. Tsai L. K., Chen Y. C., Cheng W. C., Ting C. H., Dodge J. C., Hwu W. L., Cheng S. H., and, Passini M. A,. (2012) IGF-1 delivery to CNS attenuates motor neuron cell death but does not improve motor function in type III SMA mice. Neurobiol. Dis. 45, 272-279.
69. Varea O., Arevalo M. A., Garrido J. J., Garcia-Segura L. M., Wandosell F., and, Mendez P., (2010) Interaction of estrogen receptors with insulin-like growth factor-I and Wnt signaling in the nervous system. Steroids 75, 565-569.
70. Walter L., and, Neumann H., (2009) Role of microglia in neuronal degeneration and regeneration. Semin. Immunopathol. 31, 513-525.
71. Xiao Q., Zhao W., Beers D. R., Yen A. A., Xie W., Henkel J. S., and, Appel S. H., (2007) Mutant SOD1(G93A) microglia are more neurotoxic relative to wild-type microglia. J. Neurochem. 102, 2008-2019.
72. Ye P., Carson J., and, D'Ercole A. J., (1995) In vivo actions of insulin-like growth factor-I (IGF-I) on brain myelination: studies of IGF-I and IGF binding protein-1 (IGFBP-1) transgenic mice. J. Neurosci. 15, 7344-7356.
73. Ye Y., Huang X., Zhang Y., Lai X., Wu X., Zeng X., Tang X., and, Zeng Y., (2012) Calcium influx blocked by SK&F 96365 modulates the LPS plus IFN-gamma-induced inflammatory response in murine peritoneal macrophages. Int. Immunopharmacol. 12, 384-393.
74. Zhao W., Xie W., Xiao Q., Beers D. R., and, Appel S. H., (2006) Protective effects of an anti-inflammatory cytokine, interleukin-4, on motoneuron toxicity induced by activated microglia. J. Neurochem. 99, 1176-1187.
75. Zheng W. H., and, Quirion R., (2006) Insulin-like growth factor-1 (IGF-1) induces the activation/phosphorylation of Akt kinase and cAMP response element-binding protein (CREB) by activating different signaling pathways in PC12 cells. BMC Neurosci. 7, 51.